Related Experiment Video
Updated: Jun 3, 2026
06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Design and construction of poliovirus epitope expression vectors.
K L Burke1, J W Almond, D J Evans
1Institut für Mikrobiologie der Universitat Ulm, Abteilung Virologie, Ulm, Federal Republic of Germany.
Methods in Molecular Biology (Clifton, N.J.)
|March 11, 2011
Summary
Scientists engineered a safe Sabin 1 poliovirus vaccine strain to display foreign pathogen epitopes. This live-attenuated virus, modified using recombinant DNA technology, shows potential for novel vaccine development.
Area of Science:
- Virology
- Vaccinology
- Molecular Biology
Background:
- The Sabin 1 poliovirus strain is a live-attenuated vaccine known for its safety and efficacy.
- Developing new vaccines requires innovative approaches to present foreign antigens effectively.
Purpose of the Study:
- To engineer the Sabin 1 poliovirus vaccine strain as a novel vehicle for presenting foreign pathogen epitopes.
- To explore the application of recombinant DNA technology for precise viral modification.
Main Methods:
- Utilizing recombinant DNA technology to modify cloned cDNA copies of the poliovirus genome.
- Employing infectious viral genomes in mammalian cell cultures for vaccine strain development.
Main Results:
- Successfully developed a modified live-attenuated Sabin 1 poliovirus vaccine strain.
- Demonstrated the feasibility of presenting defined foreign pathogen epitopes using this engineered virus.
Conclusions:
- The engineered poliovirus serves as a safe and effective vehicle for foreign epitope presentation.
- Recombinant DNA technology enables precise modification of the poliovirus capsid for vaccine development.
